Machine learning for identification of short-term all-cause and cardiovascular deaths among patients undergoing peritoneal dialysis patients

IF 3.9 2区 医学 Q1 UROLOGY & NEPHROLOGY Clinical Kidney Journal Pub Date : 2024-08-30 DOI:10.1093/ckj/sfae242
Xiao Xu, Zhiyuan Xu, Tiantian Ma, Shaomei Li, Huayi Pei, Jinghong Zhao, Ying Zhang, Zibo Xiong, Yumei Liao, Ying Li, Qiongzhen Lin, Wenbo Hu, Yulin Li, Zhaoxia Zheng, Liping Duan, Gang Fu, Shanshan Guo, Beiru Zhang, Rui Yu, Fuyun Sun, Xiaoying Ma, Li Hao, Guiling Liu, Zhanzheng Zhao, Jing Xiao, Yulan Shen, Yong Zhang, Xuanyi Du, Tianrong Ji, Caili Wang, Lirong Deng, Yingli Yue, Shanshan Chen, Zhigang Ma, Yingping Li, Li Zuo, Huiping Zhao, Xianchao Zhang, Xuejian Wang, Yirong Liu, Xinying Gao, Xiaoli Chen, Hongyi Li, Shutong Du, Cui Zhao, Zhonggao Xu, Li Zhang, Hongyu Chen, Li Li, Lihua Wang, Yan Yan, Yingchun Ma, Yuanyuan Wei, Jingwei Zhou, Yan Li, Jie Dong, Kai Niu, Zhiqiang He
{"title":"Machine learning for identification of short-term all-cause and cardiovascular deaths among patients undergoing peritoneal dialysis patients","authors":"Xiao Xu, Zhiyuan Xu, Tiantian Ma, Shaomei Li, Huayi Pei, Jinghong Zhao, Ying Zhang, Zibo Xiong, Yumei Liao, Ying Li, Qiongzhen Lin, Wenbo Hu, Yulin Li, Zhaoxia Zheng, Liping Duan, Gang Fu, Shanshan Guo, Beiru Zhang, Rui Yu, Fuyun Sun, Xiaoying Ma, Li Hao, Guiling Liu, Zhanzheng Zhao, Jing Xiao, Yulan Shen, Yong Zhang, Xuanyi Du, Tianrong Ji, Caili Wang, Lirong Deng, Yingli Yue, Shanshan Chen, Zhigang Ma, Yingping Li, Li Zuo, Huiping Zhao, Xianchao Zhang, Xuejian Wang, Yirong Liu, Xinying Gao, Xiaoli Chen, Hongyi Li, Shutong Du, Cui Zhao, Zhonggao Xu, Li Zhang, Hongyu Chen, Li Li, Lihua Wang, Yan Yan, Yingchun Ma, Yuanyuan Wei, Jingwei Zhou, Yan Li, Jie Dong, Kai Niu, Zhiqiang He","doi":"10.1093/ckj/sfae242","DOIUrl":null,"url":null,"abstract":"Although more and more cardiovascular risk factors have been verified in peritoneal dialysis (PD) populations in different countries and regions, it is still difficult for clinicians to accurately and individually predict death in the near future. We aimed to develop and validate machine learning-based models to predict near-term all-cause and cardiovascular death. Machine learning models were developed among 7539 PD patients, which were randomly divided into a training set and an internal test set by 5 random shuffles of 5-fold cross-validation, to predict the cardiovascular death and all-cause death in 3 months. We chose objectively-collected markers such as patient demographics, clinical characteristics, laboratory data and dialysis-related variables to inform the models and assessed the predictive performance using a range of common performance metrics, such as sensitivity, positive predictive values (PPV), the area under the receiver operating curve (AUROC) and the area under the precision recall curve (AUPRC). In the test set, the CVDformer models had a AUROC of 0.8767 (0.8129, 0.9045) and 0.9026 (0.8404, 0.9352) and AUPRC of 0.9338 (0.8134,0.9453) and 0.9073 (0.8412,0.9164) in predicting near-term all-cause death and cardiovascular death, respectively. The CVDformer models had high sensitivity and PPV for predicting all-cause and cardiovascular deaths in 3 months in our PD population. Further calibration is warranted in the future.","PeriodicalId":10435,"journal":{"name":"Clinical Kidney Journal","volume":"9 1","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Kidney Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ckj/sfae242","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Although more and more cardiovascular risk factors have been verified in peritoneal dialysis (PD) populations in different countries and regions, it is still difficult for clinicians to accurately and individually predict death in the near future. We aimed to develop and validate machine learning-based models to predict near-term all-cause and cardiovascular death. Machine learning models were developed among 7539 PD patients, which were randomly divided into a training set and an internal test set by 5 random shuffles of 5-fold cross-validation, to predict the cardiovascular death and all-cause death in 3 months. We chose objectively-collected markers such as patient demographics, clinical characteristics, laboratory data and dialysis-related variables to inform the models and assessed the predictive performance using a range of common performance metrics, such as sensitivity, positive predictive values (PPV), the area under the receiver operating curve (AUROC) and the area under the precision recall curve (AUPRC). In the test set, the CVDformer models had a AUROC of 0.8767 (0.8129, 0.9045) and 0.9026 (0.8404, 0.9352) and AUPRC of 0.9338 (0.8134,0.9453) and 0.9073 (0.8412,0.9164) in predicting near-term all-cause death and cardiovascular death, respectively. The CVDformer models had high sensitivity and PPV for predicting all-cause and cardiovascular deaths in 3 months in our PD population. Further calibration is warranted in the future.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
通过机器学习识别腹膜透析患者的短期全因死亡和心血管死亡病例
尽管在不同国家和地区的腹膜透析(PD)人群中已验证了越来越多的心血管风险因素,但临床医生仍难以准确、个性化地预测近期死亡。我们旨在开发和验证基于机器学习的模型,以预测近期全因死亡和心血管死亡。我们在7539名帕金森病患者中建立了机器学习模型,并通过5次随机洗牌的5倍交叉验证将其随机分为训练集和内部测试集,以预测3个月内的心血管死亡和全因死亡。我们选择客观收集的标记,如患者人口统计学特征、临床特征、实验室数据和透析相关变量来为模型提供信息,并使用一系列常见的性能指标来评估预测性能,如灵敏度、阳性预测值(PPV)、接收者工作曲线下面积(AUROC)和精确召回曲线下面积(AUPRC)。在测试集中,CVDformer 模型在预测近期全因死亡和心血管死亡方面的接受者操作曲线下面积分别为 0.8767 (0.8129, 0.9045) 和 0.9026 (0.8404, 0.9352),接受者操作曲线下面积分别为 0.9338 (0.8134,0.9453) 和 0.9073 (0.8412,0.9164) 。CVDformer模型在预测我们的PD人群3个月内的全因死亡和心血管死亡方面具有较高的灵敏度和PPV。今后还需要进一步校准。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical Kidney Journal
Clinical Kidney Journal Medicine-Transplantation
CiteScore
6.70
自引率
10.90%
发文量
242
审稿时长
8 weeks
期刊介绍: About the Journal Clinical Kidney Journal: Clinical and Translational Nephrology (ckj), an official journal of the ERA-EDTA (European Renal Association-European Dialysis and Transplant Association), is a fully open access, online only journal publishing bimonthly. The journal is an essential educational and training resource integrating clinical, translational and educational research into clinical practice. ckj aims to contribute to a translational research culture among nephrologists and kidney pathologists that helps close the gap between basic researchers and practicing clinicians and promote sorely needed innovation in the Nephrology field. All research articles in this journal have undergone peer review.
期刊最新文献
ERA Registry Figure of the month Heterogeneity of kidney replacement therapy incidence across Europe. Approaches to patients with obesity and CKD: focus on nutrition and surgery. GLP-1 receptor agonists in patients with chronic kidney disease and either overweight or obesity. Guidelines for the management of hypertension in CKD patients: where do we stand in 2024? New approaches to acute kidney injury.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1